2014
DOI: 10.1002/14651858.cd004098.pub2
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Levothyroxine or minimally invasive therapies for benign thyroid nodules

Abstract: No study evaluated all-cause mortality, health-related quality of life or provided systematic data on the development of thyroid cancer. Longest follow-up was five years and median follow-up was 12 months. Nodule volume reductions were achieved by PEI, LP and RF, and to a lesser extent, by LT4. However, the clinical relevance of this outcome measure is doubtful. PEI, LP and RF led to improvements in pressure symptoms and cosmetic complaints. Adverse events such as light-to-moderate periprocedural pain were see… Show more

Search citation statements

Order By: Relevance

Paper Sections

Select...
34
20
8
2

Citation Types

0
42
0
5

Year Published

Range
2015
2015
2026
2026

Publication Types

Select...
56
4
2

Relationship

0
62

Authors

Journals

citations

Cited by 62 publications

(47 citation statements)
references

References 111 publications

0
42
0
5
Order By: Relevance
How this paper cites the one you are viewing
“…After removing 42 duplicates, 193 articles remained for screening on the basis of their titles and abstracts, resulting in 29 potentially eligible articles. Upon reviewing the full text of the 29 provisionally eligible articles (Supplementary Table S1), it was found that one was a case report, 37 six were conference abstracts, 38 43 three were review articles, 44 46 one potentially involved overlapping data, 47 and three were not relevant to the field of interest. 48 –50 Ultimately, 15 articles were included in this study.…”
Section: Results
mentioning
confidence: 99%